Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

Inclusion Criteria

• •Patient is at least 18 months post transplant
• •Patient had the current transplant during the period 1 July 1997 to no less than 18 months prior to chart review
• •Patient is currently on tacrolimus/MMF or AZA - or cyclosporine/MMF or AZA based immunosuppressive therapy
• •Patient is not a recipient of dual kidney or multi -organ transplant
• •Patient has a functioning graft (i.e. patient does not require dialysis)
• •Patient is recipient of a renal transplant including living or cadaveric, related or non-related, or pediatric en bloc kidneys, but excluding kidney-pancreas transplant recipients
• •Patient received the current transplant at one of six identified regional transplant centers
• •Patient is currently followed in a regional or satellite community based nephrology clinic